Impact and mechanistic role of oral contraceptive pills on the number and epithelial type of ovarian cortical inclusion cysts; a clinicopathology and immunohistochemical study by Ali DastranjTabrizi et al.
RESEARCH Open Access
Impact and mechanistic role of oral
contraceptive pills on the number
and epithelial type of ovarian cortical
inclusion cysts; a clinicopathology and
immunohistochemical study
Ali DastranjTabrizi1, Parvin MostafaGharabaghi1, Farzam SheikhzadehHesari2*, Liela Sadeghi1,
Sharareh Zamanvandi2, Parvin Sarbakhsh3 and Morteza Ghojazadeh1
Abstract
Background: Ovarian epithelial cancers are among the most lethal women's cancers. There is no doubt about the
preventive role of oral contraceptive pills (OCPs) in development of ovarian cancers. But, there are limited numbers of
studies to address the effect of these agents on the number of cortical inclusion cysts (CICs), their epithelial type and
suppression of the metaplastic phenomenon by these pills. The aim of this study was to clarify the role of these agents
in the prevention of these cyst formation and tubal metaplasia and also examine the mesenchymal-epithelial transition
theory in this context by immunohistochemical methods.
Methods: The representative section(s) of ovarian cortex from a total number of 201 consecutive total abdominal
hysterectomy with bilateral or unilateral salpingo-oophorectomy specimens were examined for mean number of
CICs and their epithelial type between two groups of the patients. Group A included the patients who were on oral
contraceptive pills for more than 5 years. All of the subjects with other contraceptive methods or a history of less than
5 years contraceptive pills usage were stratified in group B. Sections from 20 cases in which more than five inclusion
cysts were found, were selected for IHC staining with calretinine and PAX8 as markers for mesothelium and mullerian
epithelium respectively.
Results: The mean age of the patients was 51.67 years with no significant differences between two groups. The mean
number of cysts were 1.27 and 3.23 in group A and B respectively (P =0.0001). Similarly the mean number of CICs, lined
by tubal epithelium, was significantly different between two groups (0.65 vs 2.65, P =0.0001). In IHC staining 123 out of
150 CICs (82 %) were PAX+ while only 7 CICs (4.8 %) showed positive reaction for calretinin irrespective of type of
epithelium.
Conclusion: Our findings showed that the use of OCP for more than five years in women, significantly prevents
development of cortical inclusion cysts in the ovaries which lined by tubal (PAX8 positive) type epithelium. These
findings may explain the alternative mechanism of oral contraceptive pills or long time use of progesterone in
suppression of tubal type overgrowth and subsequently prevention of ovarian epithelial cancers.
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Background
Although ovarian cancer is considered as an uncommon
malignancy, its mortality rate is the highest among gyne-
cologic malignancies in developed countries and is second
after cervical cancer in developing world [1–3]. Epithelial
ovarian cancers (EOCs) are the fifth most common cancer
in women who are living in UK and are responsible for
more than 4400 death per year in this country [4, 5]. Age
and genetics are the most well established risk factors for
ovarian cancer [6, 7]. It most commonly occurs in peri or
post-menopausal age group with the mean age of diagno-
ses occurring near 60 years. Hereditary tumors are often
diagnosed approximately 10 years earlier [8, 9]. There is a
clear association between family history for ovarian cancer
and the risk of developing ovarian cancer in subsequent
generations [8].
From historical perspective, it has been clarified that
women who use oral contraceptive pills (OCP) are in
lower risk for development of ovarian epithelial cancers.
Based on many research results, women who have taken
these agents are in one-third risk to develop ovarian can-
cer in comparison with non-users [10–13]. In the same
way, the results of a more recently research showed that
use of newly formulated pills with low estrogen and low
progesterone level had the same risk reduction effect [14].
In regard to histogenesis of ovarian epithelial cancers
particularly high grade serous carcinoma (the most lethal
type of EOC) [15], one of the relevant theories indicates
that epithelial inclusion cysts in the ovarian cortex may be
affected by mutagenic and carcinogenic agents. These
cysts may originate from ovarian mesothelium or im-
planted fimberial altered cells [16, 17]. The suppression of
ovulation and decreased level of gonadotropin levels are
considered the most important and relevant mechanisms
for risk reducing effect of OCPs. But, the number of re-
search studies to address the effect of these agents on the
number of cortical inclusion cysts, their epithelial type
and also suppression of the metaplastic phenomenon by
these pills is limited. As a known phenomenon in the endo-
metrium OCPs have suppressive effects on glandular tubal
metaplasia as well as other lesions that induced by
unopposed estrogen effects. Similarly, use of high dose pro-
gesterone in treatment of endometrial hyperplasia and well
differentiated endometriod carcinoma converts these ab-
normalities as well as tubal metaplasia to the normal
phenotype. The primary aim of this cross-sectional clinico-
pathologic and imunohistochemical study was to address
the preventive and suppressive mechanism(s) of OCPs on
the development of tubal type epithelium (PAX8 positive
cells) in the ovarian cortical cysts in OCP users and com-
pare them with control group. The secondary aim was to
characterize the immunohistochemical features of these
cysts to clarifying this issue that, the ovarian cortex micro-
environment induces tubal type (PAX8 positive) epithelium
to these structures and confirm this hypothesis that regard-
less of the origin of these cysts, progesterone has the ability
to suppress this molecular pathway and subsequently af-
fects one of the pathways that probably lead to ovarian
serous carcinogenesis. Finally, the last aim of this research
was to link the suppressive role of progesterone agents on
ovarian inclusion cyst lining and prevention of secretory
cell outgrowth (SCOUT) in these cysts.
Methods
After Tabriz university of medical sciences ethical
board approval, a cross sectional comparative study was
conducted. A total number of 201 consecutive path-
ology specimens from patients who had been under-
went to bilateral or unilateral salpigo-oophorectomy
with or without hysterectomy at alzahra teaching hos-
pital (Tabriz-Iran) from 2010 to 2012 were included.
Based on the type of contraception and the duration of
use, all of the patients stratified into the two main
groups. Group A included the patients who were on
OCP for more than 5 years (68 patients) and all of the
subjects with other contraceptive methods or a history
of less than 5 years use of OCP (133 patients) were in-
cluded in the group B. The clinical data including age,
marital status, parity, gravidity, age of menopause, past
medical history, indication for surgery and particularly
type of contraception and its duration gathered from
patients medical records. The pathological findings ex-
tracted from patients pathology reports. The represen-
tative slides from each case retrieved from pathology
file were used for examining the number of cortical in-
clusion cysts, type of their epithelium and presence or
absence of tubal metaplasia in the ovarian surface epi-
thelium. To unifying the number of cysts between the
patients with BSO and USO, and also between the cases
in which more than standard sections had been sam-
pled, the mean number of the cysts in BSO group was
taken into account. A total number of 20 cases in
which more than five inclusion cysts were found in
their representative sections, selected for IHC staining
with calretinine and PAX8. We used these markers for
identification of mesothelium and mullerian type epi-
thelium, respectively. Data were analyzed by SPSS 21
soft ware and P value less than 0.05 considered for stat-
istical significance.
Immunohistochemistry
5 μm sections from paraffin-embedded tissues were
mounted on microscope slides and underwent to heat-
mediated antigen retrieval by using 750-800 W micro-
wave oven. We used PH 9 and 6 for antigen retrieval
solution in the retrieval process for PAX8 and calretinin
respectively. Primary antibodies for detecting PAX8
(mouse monoclonal anti humanPAX8, clone BC12,
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Pleasanton CA.) and calretinin (mouse monoclonal,
clone 2E7, Biogenic) were used and detected by manu-
facturing protocol.
Results
The mean age of the 201 patients was 51.67 years (in
range of 34 to76). The mean ages of the patients in case
and control groups were 51.75 and 51.67 years with no
significant difference between two groups. 3.26 % of
cases presented with pelvic mass. Total abdominal hys-
terectomy was performed in 198 patients including 127
cases with bilateral salpingo-oophorectomy and 71 cases
with unilateral salpingo-oophorectomy. In the remaining
cases, the patients underwent for BSO or USO. The in-
dications for surgery or tissue diagnosis after surgery in
both groups of patients are shown in Table 1.
The mean number of cysts were 1.27 and 3.23 in
group A and B, respectively (P =0.0001). The mean num-
ber of CIC with flat epithelium in both groups showing
no significant difference. (0.63 Vs 0.94, P =0.11). How-
ever the mean number of CICs lined by tubal epithelium
was significantly different between two groups (0.65 in
group A vs. 2.65 in group B, P =0.0001). The mean num-
ber of the cysts with different epithelium between two
groups is illustrated in Table 2. After adjustment of both
groups for age and parity, we couldn't find any change
in the results.
In regard to immunohistochemical findings a total num-
ber of 150 cortical inclusion cysts from 20 cases with high-
est number of CIC were stained with PAX8 and calretinin.
123 out of 150 CIC (82 %) were PAX+ while only 7 CIC
(4.8 %) showed positive reaction for calretinin irrespective
of tubal or flat epithelium (p = 0.001). In all of the 14 cases
in which the surface epithelium was flat (mesothelial type),
the reaction for PAX8 was negative while, in 12 cases, this
type of epithelium was positive for calretinin (0 % vs
85 %). In contrast, in 11 cases, the metaplastic surface
epithelium was negative for PAX8 (90 %), but, 20 % of the
latter epithelium was calretinin positive (Table 3). Repre-
sentative slides from both IHC staining are illustrated in
Figs. 1 and 2.
Discussion
Epithelial ovarian cancers are the most common can-
cers of the ovary and among them; high grade serous
carcinoma is the most lethal cancer of the female geni-
tal tract. The epithelial nature of these cancers mostly
derived from the assumption that these tumors origin-
ate from ovarian surface epithelium (mesothelium)
through malignant transformation of this epithelium or
the lining of the CICs. Recent findings from numerous
studies on histogenesis of ovarian high grade serous
carcinoma strengthened this hypothesis that probably
most of these highly malignant lesions arise from fallopian
tube epithelium particularly from fimberial mucosa
[18–21]. The term STIC (Serous Tubal Intraepithelial
Carcinoma) introduced in the last decade for describing
the tubal and fimberial mucosal change which occurs
similar to other insitu carcinoma. In addition to finding
of STIC in the most of fallopian tubes which removed
for prophylactic purpose in patients who are carrier for
BRCA1 or BRCA2, in 50 to 60% of sporadic cases of
ovarian high grade serous carcinoma, this lesion has
been detected by SEE-FIM protocol in the removed fal-
lopian tubes also [22, 23].
Although the STIC hypothesis is very intriguing, how-
ever the relationship between use and particularly the
role of OCP and prevention of ovarian carcinoma has
not been addressed in this hypothesis. In the recent
study published by Banet and kurman [17], they could
not find any CIC with tubal type epithelium in the ovar-
ies of premenarchal girls, whereas a trend in increasing
Table 1 Indication for surgery or tissue diagnosis in case and
control groups
Indications for surgery or tissue diagnosis Case (n = 68) Control (133)
Leiomyoma 35 65
Ovarian mass 6 11
Ovarian cysts 6 20
Endometrial Carcinoma 3 13
AUBa 3 4
Adenomyosis 4 11
Endometrial Hyperplasia 0 3
Gestational Trophoblastic Disease 2 2
Atrophic or Unremarkable Endometrium 4 8
Cervical Intraepithelial Neoplasia 1 0
aAbnormal Uterine Bleeding
Table 2 Main number of CICsa with different type of epithelium




Main number of CIC
with flat epithelium
(%)
Main number of CIC
with tubal epithelium
(%)
A (n = 68) 1.27 0.63 0.65
B (n = 133) 3.23 0.94 2.65
P value P =0.0001 P =0.11 P =0.0001
aCortical inclusion cyst
Table 3 Immunohistochemical characteristics of ovarian CICsa
and surface epithelium in selected cases





CIC (n = 150) 123 (82 %) 7 (4.8 %) 20 P < 0.001
Surface Epithelium
(Flat type, n = 14)
0 (0 %) 12 (85 %) 2 P < 0.001
aCortical inclusion cysts
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number of ciliated type CICs with aging was seen. Pres-
ence of two types of CICs in their study and particularly
absence of CIC with tubal epithelium before menarche
lead them to this assumption that many of the ciliated
type CIC develop during the time of ovulation. Although
our findings are in line with their hypothesis, this as-
sumption is considered an anecdotal mechanistic role of
OCPs in prevention of ovarian epithelial cancers. As a
new perspective, it is well known that the epithelial lining
of the female genital tract is susceptible to tubal metapla-
sia particularly during unopposed estrogen exposure. For
example tubal metaplasia is nearly a constant finding in
the endometrial premalignant and malignant lesions and
treatment of these lesions by progesterone agents usually
suppresses the malignant epithelium and converts tubal
epithelium to normal type. In this context, the signifi-
cantly decreased number of the CICs lined by tubal type
epithelium in the our case group support this new hypoth-
esis that regardless of the site of origin, progesterone
agents have the ability to suppress tubal metaplasia or
overgrowth of the original tubal epithelium which has
been implanted on the ovarian cortex and subsequently
prevent the sequence of tubal metaplasia→ secretary cells
outgrowth→ serous carcinoma.
Regard to our immunohistochemical results, we showed
that almost all of the CICs epithelium in our study (both
with tubal or flat epithelium) were calretinin negative and
PAX8 positive whereas in 85 % of cases, in which the OSE
was found, the surface epithelium was strongly positive
for calretinin (Fig. 1, a - d). According to the Banet and
Kurman’s hypothesis [18], this phenotypic change can be
explained by this assumption that expansion of the CIC
may cause flatting of the tubal type epithelium. In cases
studied by Auersperg she found calretinin positive cells in
the flat epithelium of the CICs and has indicated for tran-
sition zone between these two types of epithelium at least
in some of these cysts [16]. The expression of PAX8 path-
way in nearly all 150 stained CICs epithelium and sup-
pression of this molecular signaling in OCP users should
be explained in detail. In the control group who were
not on long time OCPs, it can be explained in one hand
by numerous episodes of ovulation that prone the ovar-
ian cortex to formation of inclusion cysts or implant-
ation of fimberial epithelial cells. In the other hand the
suppressive effect of progesterone in the OCPs user
group may affect the PAX8 pathway genetically and
prevents tubal metaplasia or tubal type epithelium
overgrowth. This phenomenon is a well recognized
process in the endometrium and considered as a base
for treatment of well differentiated endometrial carcin-
oma by high dose progesterone.
An alternative assumption which might explain these
findings in all together is MET (Mesenchymal-epithelial
transition) theory [24]. According to this hypothesis, the
Fig. 1 Negative staining for Calretinin in multiple CICs irrespective of their flat mesothelial type epithelium (a) Negative reaction for calretinin
in a CIC with morphologically tubal type epithelium (b). PAX8 positivity in a CIC with tubal epithelium (c). Strong positive reaction for calretinin in
ovarian surface epithelium (d)
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ovarian cortical microenvironment has a dramatic influ-
ence on the epithelium of CICs and induced epithelial
markers expression on the migrated cells. Regardless of
the origin of CIC epithelium from ovarian surface epithe-
lium or fimberial implanted cells, it seems that the PAX8
pathway is expressed dominantly in the absence of proges-
terone, whereas the presence of relatively dominant level
of progesterone may convert this pathway. As noted in
the result section, 82 % of CICs, regardless of their lining
phenotype, were positive for PAX8 while only 4.8 % of
these CICs were calretinin positive (Fig. 1c). These find-
ings were in line with previous research findings and con-
firm MET (Mesenchymal-epithelial transition) theory
[24]. Interestingly our results also support the reverse
phenomenon named epithelial –mesenchymal transition.
Surprisingly in 20 % of IHC stained slides, the superficially
located tubal type epithelium showed positive reaction for
calretinin regardless of its phenotype. These findings are
in line with the previous findings which indicate that
presumably the high concentration of bioactive materials
secreted by OSE in closed lumen of CICs induces epithe-
lial markers acquisition regardless of their phenotypes
[25–27] (Fig. 1c). In contrast when we encounter with sur-
face epithelium invaginations which have opened orifice,
the lining epithelium shows calretinin positivity and PAX8
negativity irrespective of their phenotype (Fig. 2 a and b).
In similar fashion, 90 % of cases in which the surface
epithelium had acquired the tubal type phenotype, this
epithelium were negative for PAX8 (Fig. 2c). Although the
number of cases in relation to the latter findings were
limited, these results confirm the effects of tissue micro-
environment in acquisition or losing of cell markers re-
gardless of their phenotype or origin.
Conclusion
In summary our findings in the present study highlighted
the progesterone role of OCPs in prevention of tubal
metaplasia or tubal type epithelium overgrowth in the
Fig. 2 PAX8 negativity in a CIC with tubal and flat epithelium which has opened orifice (a). Calretinin positivity in the surface epithelium with
tubal phenotype (b). PAX 8 negative reaction in surface epithelium with tubal phenotype (c). Negative reaction for calretinin in a CIC with closed
lumen (b)
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ovarian cortical inclusion cysts. We not only showed
that the number of CICs lined by tubal epithelium has
been decreased significantly in OCP users but also
showed that probably progesterone of oral contracep-
tive pills suppresses the PAX8 pathway and prevents
the sequence of tubal metaplasia→ secretary cells out-
growth (SCOUT)→ serous carcinoma. In addition,
our IHC findings explain how the ovarian cortical
microenvironment affects the nature of cortical cysts
epithelium in the presence or absence of oral contra-
ceptive pills.
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